×

Treatments using transgenic goat produced antithrombin III

  • US 7,019,193 B2
  • Filed: 07/02/2002
  • Issued: 03/28/2006
  • Est. Priority Date: 02/21/1995
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method of treating a subject having an ATIII deficiency or inflammation, comprising:

  • administering to the subject goat mammary gland produced antithrombin III having a monosaccharide composition which comprises a higher level of mannose than plasma derived antithrombin III, wherein thrombin is inhibited.

View all claims
  • 6 Assignments
Timeline View
Assignment View
    ×
    ×